Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)

ClinicalTrials.gov ID: NCT01912196

Public ClinicalTrials.gov record NCT01912196. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 6:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled, Randomized Add-On Study of MSI-195 (Methylation Sciences Inc. S-Adenosyl-L-Methionine, SAMe) For Patients With Major Depressive Disorder(MDD) Who Have Had An Inadequate Response to Current Antidepressant Therapy

Study identification

NCT ID
NCT01912196
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
MSI Methylation Sciences, Inc.
Industry
Enrollment
376 participants

Conditions and interventions

Interventions

  • MSI-195 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
21 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2013
Primary completion
Aug 31, 2015
Completion
Aug 31, 2015
Last update posted
Mar 17, 2016

2013 – 2015

United States locations

U.S. sites
35
U.S. states
17
U.S. cities
33
Facility City State ZIP Site status
MSI Investigational Site Birmingham Alabama 35216
MSI Investigational Site Encino California 91316
MSI Investigational Site Escondido California 92025
MSI Investigational Site Garden Grove California 92845
MSI Investigational Site Los Alamitos California 90720
MSI Investigational Site Los Angeles California 90024
MSI Investigational Site National City California 91950
MSI Investigational Site Newport Beach California 92660
MSI Investigational Site Oakland California 94612
MSI Investigational Site Oceanside California 92056
MSI Investigational Site Torrance California 90502
MSI Investigational Site Jacksonville Florida 32256
MSI INvestigational Site Kissimmee Florida 34741
MSI Investigational Site Lauderhill Florida 33319
MSI Investigational Site Orlando Florida 32806
MSI Investigational Site Atlanta Georgia 30328
MSI Investigational Site Hoffman Estates Illinois 60169
MSI Investigational Site Towson Maryland 21285
MSI Investigational Site Flowood Mississippi 39232
MSI Investigational Site Las Vegas Nevada 89102
MSI Investigational Site Marlton New Jersey 08053
MSI Investigational Site Albuquerque New Mexico 87109
MSI Investigational Site New York New York 10128
MSI Investigational Site Rochester New York 14618
MSI Investigational Site Canton Ohio 44718
MSI Investigational Site Dayton Ohio 45417
MSI Investigational Site Portland Oregon 97210
MSI Investigational Site Memphis Tennessee 38119
MSI Investigational Site Austin Texas 78731
MSI Investigational Site Austin Texas 78754
MSI Investigational Site Dallas Texas 75231
MSI Investigational Site Houston Texas 77008
MSI Investigational Site Houston Texas 77098
MSI Investigational Site Murray Utah 84123
MSI Investigational Site Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01912196, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 17, 2016 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01912196 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →